In the late 1980s, the Prospective Payment System and the expansion of managed care plans forced hospitals to be cost efficient. The increased number of hospital mergers suggests that merging is a way to become more efficient to ensure long-run survival. This study presents an economic framework...

In the last decades, many European hospital markets witnessed a wave of mergers leading to increased levels of market concentration. The effects of hospital mergers and the effectiveness of competition enforcement have been discussed by politicians but understudied by academics. This report...

In den letzten Jahrzehnten kam es auf vielen europäischen Krankenhausmärkten zu einer Fusionswelle, die zu einer zunehmenden Marktkonzentration geführt hat. Die Auswirkungen von Krankenhausfusionen und die wirksame Durchsetzung von Wettbewerbsrecht wurden von der Politik diskutiert, aber...

In the last decades, many European hospital markets witnessed a wave of mergers leading to increased levels of market concentration. The effects of hospital mergers and the effectiveness of competition enforcement have been discussed by politicians but understudied by academics. This report...

In den letzten Jahrzehnten kam es auf vielen europäischen Krankenhausmärkten zu einer Fusionswelle, die zu einer zunehmenden Marktkonzentration geführt hat. Die Auswirkungen von Krankenhausfusionen und die wirksame Durchsetzung von Wettbewerbsrecht wurden von der Politik diskutiert, aber...

We develop a simultaneous equations estimation framework to understand the interactions among generic entry, prices, and market shares. We base our estimates on a panel data sample of 40 brand-name drugs that first experienced generic competition during the period July 1992-January 1998. We find...

In 2011, Bristol-Myers Squibb set the price of its newly approved melanoma drug ipilimumab—brand name Yervoy—at $120,000 for a course of therapy. The drug was associated with an incremental increase in life expectancy of four months. Drugs like ipilimumab have fueled the perception that the...

General Practitioners (GP) have limited means to compete. As quality is hard to observe by patients, GPs have incentives to signal quality by using instruments patients perceive as quality.

This study examines the impact of major health insurance reform on payments made in the health care sector. We study the prices of services paid to physicians in the privately insured market during the Massachusetts health care reform. The reform increased the number of insured individuals as...

This study assesses the impact of competition on quality and price in the English care/nursing homes market. Considering the key institutional features, we use a theoretical model to assess the conditions under which further competition could increase or reduce quality. A dataset comprising the...